<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-38-people-with-obesity-may-have-a-higher-risk-of-dementia</loc><lastmod>2026-01-22T14:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-15-igsf11-vista-is-a-critical-and-targetable-immune-checkpoint-axis-in-diffuse-midline-glioma</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-79-a-single-cell-atlas-of-the-woodchuck-liver-reveals-cellular-programs-conserved-in-human-hbv-infection</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-8-tumor-antigen-independent-targeting-of-solid-tumors-by-armored-macrophage-directed-anti-trem2-car-t-cells</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-81-updated-data-from-imbrave050-adjuvant-atezolizumab-plus-bevacizumab-for-high-risk-hepatocellular-carcinoma</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-74-heat-shock-protein-70s-are-modifiers-of-endothelial-function-in-fabry-disease</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-73-primary-hyperoxaluria-s-from-trials-to-real-life-data-and-pipeline-therapies</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-9-armored-macrophage-targeted-car-t-cells-reset-and-reprogram-the-tumor-microenvironment-and-control-metastatic-cancer-growth</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-43-reconstruction-of-a-devastated-ureter-multi-institutional-experience-with-robotic-intracorporeal-ileal-ureter-replacement</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07358741</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07359586</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-78-yttrium-90-radioembolization-is-associated-with-a-lower-risk-of-liver-transplant-waitlist-dropout-than-chemoembolization-in-hepatocellular-carcinoma</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-80-incidence-and-implications-of-abstinence-induced-recompensation-in-alcohol-related-cirrhosis</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct04656080</loc><lastmod>2026-01-22T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-13-reply-to-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-cell-lung-cancer-and-beyond</loc><lastmod>2026-01-22T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-96-reply-to-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-cell-lung-cancer-and-beyond</loc><lastmod>2026-01-22T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-81-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-cell-lung-cancer-and-beyond</loc><lastmod>2026-01-22T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-12-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-cell-lung-cancer-and-beyond</loc><lastmod>2026-01-22T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-15-bridging-the-gap-advancing-first-line-therapy-for-patients-with-metastatic-human-epidermal-growth-factor-receptor-2-positive-breast-cancer</loc><lastmod>2026-01-22T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-16-bridging-the-gap-advancing-first-line-therapy-for-patients-with-metastatic-human-epidermal-growth-factor-receptor-2-positive-breast-cancer</loc><lastmod>2026-01-22T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-35-new-guide-promotes-safe-inclusive-and-child-friendly-public-spaces</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-28-new-guide-promotes-safe-inclusive-and-child-friendly-public-spaces</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07240935</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-44-active-surveillance-versus-intravesical-bacillus-calmette-gu-rin-for-high-grade-t1-bladder-cancer-with-negative-second-transurethral-resection-the-randomized-noninferiority-phase-3-jcog1019-trial</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-82-af6-knockout-induced-upregulation-of-bile-acid-production-promotes-cxcl14-mediated-antitumor-immunity-in-hcc</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07352111</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07343843</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-10-who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-11-new-guide-promotes-safe-inclusive-and-child-friendly-public-spaces</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-75-eligibility-timing-and-organ-quality-indications-and-outcomes-of-kidney-transplantation-in-older-patients</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-76-a-predictor-finding-study-found-patient-reported-outcomes-improve-the-prediction-of-mortality-of-incident-dialysis-patients</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct05423301</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07356245</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07002476</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-27-who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-34-who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day</loc><lastmod>2026-01-21T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-20-randomized-phase-ii-iii-trial-comparing-hepatectomy-followed-by-mfolfox6-with-hepatectomy-alone-for-liver-metastasis-from-colorectal-cancer-long-term-results-of-jcog0603</loc><lastmod>2026-01-21T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-53-is-unmutated-igg1-a-wrong-choice-for-therapeutic-antibodies-targeting-immune-checkpoints-lessons-from-the-clinical-failures-of-the-first-anti-tigit-antibodies</loc><lastmod>2026-01-21T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-54-is-it-time-to-move-beyond-graft-versus-host-disease-free-relapse-free-survival-as-a-primary-end-point-in-clinical-trials-for-hematopoietic-cell-transplantation-</loc><lastmod>2026-01-21T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-58-is-it-time-to-move-beyond-graft-versus-host-disease-free-relapse-free-survival-as-a-primary-end-point-in-clinical-trials-for-hematopoietic-cell-transplantation-</loc><lastmod>2026-01-21T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-57-is-unmutated-igg1-a-wrong-choice-for-therapeutic-antibodies-targeting-immune-checkpoints-lessons-from-the-clinical-failures-of-the-first-anti-tigit-antibodies</loc><lastmod>2026-01-21T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-21-randomized-phase-ii-iii-trial-comparing-hepatectomy-followed-by-mfolfox6-with-hepatectomy-alone-for-liver-metastasis-from-colorectal-cancer-long-term-results-of-jcog0603</loc><lastmod>2026-01-21T08:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07315087</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07351799</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-77-taking-the-unknown-out-of-ckdu-optimizing-approaches-to-uncover-the-cause-s-of-epidemic-level-kidney-disease-in-low-and-middle-income-settings-a-report-from-the-isn-s-international-consortium-of-ckdu-collaborators-isn-i3c-</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-78-multi-omics-analyses-reveal-the-pathogenic-role-of-terminal-ileum-derived-iga-7-cells-in-iga-nephropathy</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-79-uremia-and-parathyroid-hormone-have-distinct-effects-on-bone-protein-and-gene-expression</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-33-hiding-in-plain-sight-the-neuro-protective-benefit-of-tropomyosin-receptor-kinase-inhibition-in-non-neurotrophic-receptor-tyrosine-kinase-driven-lung-cancers</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct03237702</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-80-a-secondary-analysis-of-the-testing-trial-predicted-individual-patient-response-to-corticosteroid-treatment-in-iga-nephropathy</loc><lastmod>2026-01-20T12:00:00.000Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url></urlset>